Table 1 Correlation between miR-484 expression levels and clinical features in gastric cancer patients
From: Downregulation of miR-484 is associated with poor prognosis and tumor progression of gastric cancer
Parameters | Cases No. (n = 124) | miR-484 expression | P | |
|---|---|---|---|---|
Low (n = 69) | High (n = 55) | |||
Age | ||||
  < 60 | 63 | 33 | 30 | 0.269 |
  ≥ 60 | 61 | 36 | 25 | |
Gender | ||||
 Male | 76 | 37 | 39 | 0.632 |
 Female | 48 | 32 | 16 | |
Differentiation | ||||
 Well + Moderate | 71 | 29 | 42 | 0.006 |
 Poor | 53 | 40 | 13 | |
T Stage | ||||
 T1-T2 | 64 | 34 | 30 | 0.388 |
 T3-T4 | 60 | 35 | 25 | |
Lauren classification | ||||
 Intestinal | 68 | 33 | 25 | 0.504 |
 Diffused | 56 | 26 | 30 | |
Lymph node metastasis | ||||
 Negative | 57 | 24 | 33 | 0.015 |
 Positive | 67 | 45 | 22 | |
Distant metastasis | ||||
 Negative | 93 | 47 | 46 | 0.005 |
 Positive | 31 | 22 | 9 | |
TNM stage | ||||
 I - II | 55 | 26 | 29 | 0.002 |
 III - IV | 69 | 43 | 26 | |